Matthew T Plavan - Net Worth and Insider Trading
Matthew T Plavan Net Worth
The estimated net worth of Matthew T Plavan is at least $1,051 dollars as of 2024-09-22. Matthew T Plavan is the CEO of Arcadia Biosciences Inc and owns about 357 shares of Arcadia Biosciences Inc (RKDA) stock worth over $1,046. Matthew T Plavan is also the Former CEO of ThermoGenesis Holdings Inc and owns about 27 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $5. Details can be seen in Matthew T Plavan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew T Plavan has not made any transactions after 2020-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew T Plavan
Matthew T Plavan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew T Plavan owns 3 companies in total, including Arcadia Biosciences Inc (RKDA) , ThermoGenesis Holdings Inc (THMO) , and Origin Materials Inc (ORGN) .
Click here to see the complete history of Matthew T Plavan’s form 4 insider trades.
Insider Ownership Summary of Matthew T Plavan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RKDA | Arcadia Biosciences Inc | 2020-08-03 | Chief Financial Officer |
THMO | ThermoGenesis Holdings Inc | 2015-09-02 | Chief Financial Officer |
ORGN | Origin Materials Inc | 2023-10-30 | Chief Financial Officer |
Matthew T Plavan Latest Holdings Summary
Matthew T Plavan currently owns a total of 2 stocks. Among these stocks, Matthew T Plavan owns 357 shares of Arcadia Biosciences Inc (RKDA) as of August 3, 2020, with a value of $1,046 and a weighting of 99.54%. Matthew T Plavan also owns 27 shares of ThermoGenesis Holdings Inc (THMO) as of September 2, 2015, with a value of $5 and a weighting of 0.46%.
Latest Holdings of Matthew T Plavan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RKDA | Arcadia Biosciences Inc | 2020-08-03 | 357 | 2.93 | 1,046 |
THMO | ThermoGenesis Holdings Inc | 2015-09-02 | 27 | 0.18 | 5 |
Holding Weightings of Matthew T Plavan
Matthew T Plavan Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew T Plavan has made a total of 3 transactions in Arcadia Biosciences Inc (RKDA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Arcadia Biosciences Inc is the acquisition of 15 shares on August 3, 2020, which cost Matthew T Plavan around $1,849.
According to the SEC Form 4 filings, Matthew T Plavan has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the sale of 2 shares on September 2, 2015, which brought Matthew T Plavan around $11,744.
Insider Trading History of Matthew T Plavan
- 1
Matthew T Plavan Trading Performance
GuruFocus tracks the stock performance after each of Matthew T Plavan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew T Plavan is -9.13%. GuruFocus also compares Matthew T Plavan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew T Plavan within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew T Plavan's insider trading performs compared to the benchmark.
Performance of Matthew T Plavan
Matthew T Plavan Ownership Network
Matthew T Plavan Owned Company Details
What does Arcadia Biosciences Inc do?
Who are the key executives at Arcadia Biosciences Inc?
Matthew T Plavan is the Chief Financial Officer of Arcadia Biosciences Inc. Other key executives at Arcadia Biosciences Inc include Chief Financial Officer Thomas J. Schaefer , Chief Executive Officer Stanley Jr Jacot , and Chief Financial Officer Pamela Haley .
Arcadia Biosciences Inc (RKDA) Insider Trades Summary
Over the past 18 months, Matthew T Plavan made no insider transaction in Arcadia Biosciences Inc (RKDA). Other recent insider transactions involving Arcadia Biosciences Inc (RKDA) include a net purchase of 2,049 shares made by Thomas J. Schaefer , a net purchase of 5,000 shares made by Stanley Jr Jacot , and a net purchase of 700 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Arcadia Biosciences Inc (RKDA) in total and bought 1,400 shares, with a net purchase of 1,400 shares. During the past 18 months, 0 shares of Arcadia Biosciences Inc (RKDA) were sold and 7,749 shares were bought by its insiders, resulting in a net purchase of 7,749 shares.
Arcadia Biosciences Inc (RKDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcadia Biosciences Inc Insider Transactions
Matthew T Plavan Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew T Plavan. You might contact Matthew T Plavan via mailing address: C/o Thermogenesis Corp., 2711 Citrus Road, Rancho Cordova Ca 95742.